| Literature DB >> 33396667 |
Nasir Mahmood1,2,3, Sarah Bushra Nasir4, Kathleen Hefferon3.
Abstract
The coronavirus SARS-CoV-2 has turned our own health and the world economy upside down. While several vaccine candidates are currently under development, antivirals with the potential to limit virus transmission or block infection are also being explored. Plant production platforms are being used to generate vaccines and antiviral proteins inexpensively and at mass scale. The following review discusses the biology and origins of the current coronavirus pandemic, and describes some of the conventional, synthetic, and plant-based approaches to address the challenge that it presents to our way of life.Entities:
Keywords: antibodies; antivirals; coronavirus; plants; vaccines
Year: 2020 PMID: 33396667 PMCID: PMC7823519 DOI: 10.3390/vaccines9010015
Source DB: PubMed Journal: Vaccines (Basel) ISSN: 2076-393X